Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity - Williams, K H; Ribeiro de, AJ V; Prakoso, E (Diabetes Res Clin Pract, 2015)
et al.